Immunic, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 29.58 million compared to USD 25.27 million a year ago. Basic loss per share from continuing operations was USD 0.3 compared to USD 0.58 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 USD | 0.00% | -1.93% | -15.33% |
May. 08 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.33% | 114M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.90% | 21.97B | |
-4.73% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- IMUX Stock
- News Immunic, Inc.
- Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024